Cytophage Technologies Ltd. (TSXV:CYTO)
0.110
+0.015 (15.79%)
At close: Mar 6, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 7.45 million as of March 6, 2026. Its market cap has decreased by -48.87% in one year.
Market Cap
7.45M
Enterprise Value
8.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has increased from 5.25M to 7.45M, an increase of 41.82%. That is a compound annual growth rate of 8.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.45M | -26.67% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 6.36M |
| COSCIENS Biopharma | 6.72M |
| Quest PharmaTech | 5.92M |
| Restart Life Sciences | 7.11M |
| PharmaTher Holdings | 7.28M |
| Aptose Biosciences | 5.51M |
| Marvel Biosciences | 7.54M |
| MYND Life Sciences | 5.22M |